Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on ...

Medicare Part D is introducing important prescription drug cost updates in 2026, including higher deductibles, a new ...

GLP-1 weight loss drugs just got a lot cheaper for many older Americans. Starting Wednesday, the federal government is ...

Medicare drug plan changes in 2026 may raise your prescription costs. Here is what beneficiaries need to know about ...

As anti-obesity drugs Wegovy (semaglutide) and Mounjaro (tirzepatide) will be reimbursed as of Monday, June 15, the secretaries of the specialized obesity center (CSO) at the Pitié-Salpêtrière ...

For stories on healthy living, subscribe to NPR's Health newsletter. Every time David Davis talks to a nurse at Vida Health, he thinks he'll finally get the OK for Zepbound. And every time so far he ...

For stories on healthy living, subscribe to NPR's Health newsletter. Every time David Davis talks to a nurse at Vida Health, he thinks he'll finally get the OK for Zepbound. And every time so far he ...

President Trump on Friday announced that over 100 prescription medications would be added to his administration’s direct-to-consumer drug platform, TrumpRx, the second expansion of the initiative in ...

President Donald Trump on Friday announced a major expansion of his administration's initiative aimed at helping Americans access discounted prescription medications. In a Truth Social post, Trump ...

A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself.

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.